HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade Glioma.
第一作者:
Jo,Sasame
第一单位:
Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.;Neurosurgical-Oncology Laboratory, Yokohama City University, Yokohama, Japan.
作者:
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);脑肿瘤(Brain Neoplasms);细胞系, 肿瘤(Cell Line, Tumor);抗药性, 肿瘤(Drug Resistance, Neoplasm);神经胶质瘤(Glioma);HSP90热休克蛋白质类(HSP90 Heat-Shock Proteins);人类(Humans);黑色素瘤(Melanoma);丝裂原激活蛋白激酶激酶类(Mitogen-Activated Protein Kinase Kinases);分子靶向治疗(Molecular Targeted Therapy);突变(Mutation);肿瘤复发, 局部(Neoplasm Recurrence, Local);蛋白激酶抑制剂(Protein Kinase Inhibitors);原癌基因蛋白质B-raf(Proto-Oncogene Proteins B-raf);原癌基因蛋白质c-akt(Proto-Oncogene Proteins c-akt)
DOI
10.1158/1078-0432.CCR-21-3622
PMID
35344043
发布时间
2022-07-05
- 浏览0

Clinical cancer research
2425-2439页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文